Connect with a clinic liaison to explore how we can support your practice
Published human trials of DSIP are decades old, used very small samples, and produced mixed results
Products discussed are not intended to diagnose, treat, cure, or prevent any disease
The CagriSema metabolic preservation mechanism, specifically the maintenance of mitochondrial function in skeletal muscle during weight loss, could theoretically slow the rate of weight regain by preventing some of the metabolic adaptation that makes regain almost inevitable
This article explains what cagrilintide is, how amylin biology differs from GLP-1 biology, why the combination with semaglutide is research-meaningful, and what Canadian researchers should understand about this emerging peptide category